Table 1:

Demographic characteristics of patients with clinically isolated syndrome and other neurologic disorders and healthy controlsa

CIS (n = 48)HC (n = 47)PONDb (n = 30)Pc
Male/female11:3712:35.7667:23.827
Age (yr) (mean)40.7 ± 11.640.1 ± 10.7.81440.9 ± 15.6.780
Age at diagnosis (yr) (mean)38.3 ± 11.634.6 ± 17.1
Disease duration (yr) (mean)2.8 ± 3.912.3 ± 11.2
Expanded Disability Status Scale (median ± IQR)1.5 ± 1
Disease modifying therapy (No.) (%)
    No therapy21, 43.8
    Interferon β 1a19, 39.6
    Glatiramer acetate7, 14.5
    Other1, 2.1
Type of OND (No.) (%)b
    Degenerative10 (33.3)
    Autoimmune10 (33.3)
    Vascular10 (33.3)
WM-SAV5.1 ± 8.80.1 ± 0.3<.0013.4 ± 8.6.042
Normalized brain volume1532.6 ± 61.91556.4 ± 77.9.1031549.3 ± 101.733
Normalized GM volume785.8 ± 45.7783.6 ± 45.1.814786.9 ± 82.5.816
Normalized WM volume746.9 ± 28.9772.8 ± 49.8.003762.4 ± 37.6.332
Normalized lateral ventricle volume36.6 ± 15.230.5 ± 10.3.03236.2 ± 21.9.151
  • Note:—CIS indicates clinically isolated syndrome; HC, healthy controls; IQR, interquartile range; OND, other neurological disorders; –, not applicable; WA-SAV, white matter signal abnormality volume.

  • a Values are presented as means. Volumetric measurements are presented in milliliters. Groups were compared using the χ2 test and Student t test.

  • b Degenerative disease group (n = 10) included patients with Parkinson disease (n = 6), epilepsy (n = 2), cerebellum syndrome (n = 1), and dementia (n = 1); autoimmune disease group (n = 10) included patients with antiphospholipid syndrome (n = 4), systemic lupus erythematosus (n = 3), neurosarcoidosis (n = 1), acute disseminated encephalomyelitis (n = 1), and chronic fatigue syndrome (n = 1); neurovascular disease group (n = 10) included patients with migraine (n = 7), transitory ischemic attack (n = 1), headache (n = 1), and CNS vasculitis (n = 1).

  • c P value of OND vs HC.